Skip to content

Where does federal science funding stand now?

Science Friday

Hosted by Flora Lichtman

12m
Transcript

Original podcast

Where to listen

Summary

Written by a model from the transcript; not yet reviewed.

This episode examines the state of federal science funding midway through the second Trump administration, featuring Dr. Sudip Parikh, CEO of the American Association for the Advancement of Science. The discussion explores how bipartisan congressional appropriations kept headline science funding relatively level despite deep initial proposed cuts, while administrative delays and a shift toward multi-year funding created severe transition shocks for early-career researchers and small businesses. The conversation also addresses ongoing uncertainties around personnel levels across federal agencies, the potential impacts of executive restrictions on grant language, and the emergence of scientists winning seats in Congress during the midterms.

  • Congress ultimately passed appropriations bills that kept overall science funding relatively level despite catastrophic initial budget proposals. 1:40
  • Transitioning rapidly to multi-year funding models can drastically reduce the number of active grants available to early-career researchers. 3:32
  • Federal agencies like the NSF and NIH have seen staffing declines between twenty and thirty percent compared to recent years. 8:56
  • Executive branch control over agency operations and grant distribution limits how much oversight or immediate correction Congress can enforce. 10:13

Chapters

  1. 0:02
    Episode Introduction and Context

    Hosts introduce the episode, noting the midterm context and the state of federal science funding.

  2. 0:46
    Congressional Response to 2025 Budget Cuts

    Sudip Parikh explains how Congress pushed back against the Trump administration's proposed cuts to NIH, NSF, and NASA.

  3. 2:52
    Apportionment Delays and Funding Flow

    The discussion turns to the slow process of apportioning appropriated money to agencies and the impact on grant disbursement.

  4. 3:32
    Multi‑Year Funding Transition and Its Consequences

    Parikh details how the shift to multi‑year funding hurt early‑career scientists and reduced grant availability.

  5. 5:46
    Brain Drain and Talent Pipeline Issues

    The hosts explore data gaps on scientist migration and the broader concerns about the domestic talent pipeline.

  6. 7:11
    DEI‑Related Grant Restrictions and Uncertainty

    Parikh discusses lingering concerns about DEI restrictions and the uncertainty they create for researchers.

  7. 8:40
    Rehiring and Staffing Levels in Federal Agencies

    The conversation covers the extent of rehiring after layoffs at agencies like the FDA, EPA, and CDC.

  8. 9:38
    The STEM Wave and Congressional Support

    Hosts reflect on the influx of scientists into Congress and the potential for bipartisan support of science.

  9. 11:02
    Looking Forward: Resilience and Guardrails

    Parikh offers a hopeful outlook, emphasizing resilience, oversight, and the need for guardrails in the next two years.

Highlights

  • 1:18

    Bipartisan Pushback on Budget Cutsdata

    Despite proposals seeking fifty percent cuts to agencies like the NIH and NSF, a Republican-majority Congress pushed back and passed appropriations bills keeping science funding level.

  • 2:18

    Public Advocacy Drove Congressional Actioninsight

    The guest explains that Congress did not protect science funding on its own initiative; rather, scientists, patients, and companies actively spoke up in favor of federal support.

  • 3:52

    The Hidden Costs of Multi-Year Grantsstrategy

    Distributing multi-year funding all at once causes a steep drop in the number of new grants issued that year, disproportionately hurting early-career scientists and small businesses.

  • 8:56

    Significant Federal Staffing Reductionsdata

    Federal agencies face large staff shortages, with the National Science Foundation missing over thirty percent of its staff and the NIH down twenty to thirty percent compared to 2019 levels.

  • 10:13

    Limits of Congressional Oversightinsight

    The guest notes that while a record number of scientists were elected to Congress, the executive branch retains extensive power over agency execution, limiting what legislators can immediately fix.

Quotes

  • “And Congress, in a very bipartisan way, remember, it was a Republican-majority Congress, by May started pushing back.”
    Unnamed speaker · 1:26
  • “Now, unfortunately, some of that went out as something called multi-year funding.”
    Unnamed speaker · 3:32
  • “And I think I worry much more about that in terms of our domestic talent.”
    Unnamed speaker · 6:32
  • “There are lawsuits underway right now that might, through the discovery process, tell us.”
    Unnamed speaker · 7:29
  • “And I realized that, yes, there are scientists who are the sort of beginning point of that.”
    Unnamed speaker · 11:09

About this episode

Sudip Parikh of AAAS joins us for an update on how federal funding for research has changed, and the impact of those changes.

Transcript

0:00
12:28

2,176 words · 2 speakers

Speaker names marked are inferred from speaking time and the show’s known hosts — they are not voice-verified.

Topics

  • National Science Foundation
  • American Association for the Advancement of Science
  • NASA
  • FDA
  • National Institutes of Health
  • EPA
  • CDC
  • White House Office of Management and Budget
  • National Science Board
  • DEI

Page updated · transcript and summary are machine-generated